Infertility Clinical Trial
— SIRIUSOfficial title:
MeaSuring Free radIcals With Diamond magnetometrRy In hUman Single Sperm Cells Related to Microbiota and Lifestyle Factors
The cause of infertility can be due to a female factor or a male factor. In case of a male factor, it is often due to poor semen quality. However, the cause of poor quality is often unknown. In previous research, infertility problems in men were related to chemical processes in metabolism causing the formation of free radicals. Free radicals are physiological by-products of our body mechanisms. Free radicals are very reactive and can therefore react with a lot of molecules of cells within our body and cause damage. A balance between free radicals, which are also needed for physiological processes in the body, and antioxidants, which defuses the reactive free radicals, is most desirable. However, as stated in literature, there are a lot of factors that can influence extra free radical production, which causes overloading of the system, resulting in damage on cellular level. Free radicals in semen plasma and on the sperm cell could play a role in male infertility. Nonetheless, free radicals are not used as diagnostic markers due to the lack of detection systems, as free radicals are very short-lived. This study aims to introduce a new technique, called diamond magnetometry, to measure free radicals directly on the sperm cell and in serum. Diamond magnetometry involves very small diamond particles as magnetic sensors that engage a reaction with the free radicals on the sperm cell, causing signals that can be measured. To compare local free radical production with systemic free radical production, other diagnostic biomarkers are also measured in serum. It is hypothesized that the composition of seminal microbiome could influence the free radical concentration. Therefore, this study also aims to explore the microbiota composition and see if this has an influence in semen quality and free radical production. At last, this study also want to correlate standard semen parameters (defined by the World Health Organisation), lifestyle factors and food intake, to detect a role for lifestyle in the production of free radicals.
Status | Not yet recruiting |
Enrollment | 80 |
Est. completion date | March 31, 2027 |
Est. primary completion date | October 31, 2026 |
Accepts healthy volunteers | No |
Gender | Male |
Age group | 18 Years to 55 Years |
Eligibility | Inclusion Criteria: - Males of couples visiting the CRM at the UMCG between 18-55 years old. - Planned semen-analysis as standard care. Exclusion Criteria: - Males who receive(d) chemo- and/or radiotherapy, use(d) testosterone suppletion and/or anabolic steroids - Males who are azoospermic - Males who have an abnormal SA due to genetic causes. - Semen analysis with round cells >2x106 /ml (as marker for infection) - Males who currently use antibiotics |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
University Medical Center Groningen |
Agarwal A, Rana M, Qiu E, AlBunni H, Bui AD, Henkel R. Role of oxidative stress, infection and inflammation in male infertility. Andrologia. 2018 Dec;50(11):e13126. doi: 10.1111/and.13126. — View Citation
Baud D, Pattaroni C, Vulliemoz N, Castella V, Marsland BJ, Stojanov M. Sperm Microbiota and Its Impact on Semen Parameters. Front Microbiol. 2019 Feb 12;10:234. doi: 10.3389/fmicb.2019.00234. eCollection 2019. — View Citation
Bourgonje AR, Gabriels RY, de Borst MH, Bulthuis MLC, Faber KN, van Goor H, Dijkstra G. Serum Free Thiols Are Superior to Fecal Calprotectin in Reflecting Endoscopic Disease Activity in Inflammatory Bowel Disease. Antioxidants (Basel). 2019 Sep 1;8(9):351. doi: 10.3390/antiox8090351. — View Citation
Ciobanu L, Seeber DA, Pennington CH. 3D MR microscopy with resolution 3.7 microm by 3.3 microm by 3.3 microm. J Magn Reson. 2002 Sep-Oct;158(1-2):178-82. doi: 10.1016/s1090-7807(02)00071-x. — View Citation
Cooper TG, Noonan E, von Eckardstein S, Auger J, Baker HW, Behre HM, Haugen TB, Kruger T, Wang C, Mbizvo MT, Vogelsong KM. World Health Organization reference values for human semen characteristics. Hum Reprod Update. 2010 May-Jun;16(3):231-45. doi: 10.1093/humupd/dmp048. Epub 2009 Nov 24. — View Citation
DiGuiseppi J, Fridovich I. The toxicology of molecular oxygen. Crit Rev Toxicol. 1984;12(4):315-42. doi: 10.3109/10408448409044213. — View Citation
Farahani L, Tharakan T, Yap T, Ramsay JW, Jayasena CN, Minhas S. The semen microbiome and its impact on sperm function and male fertility: A systematic review and meta-analysis. Andrology. 2021 Jan;9(1):115-144. doi: 10.1111/andr.12886. Epub 2020 Oct 7. — View Citation
Hou D, Zhou X, Zhong X, Settles ML, Herring J, Wang L, Abdo Z, Forney LJ, Xu C. Microbiota of the seminal fluid from healthy and infertile men. Fertil Steril. 2013 Nov;100(5):1261-9. doi: 10.1016/j.fertnstert.2013.07.1991. Epub 2013 Aug 29. — View Citation
Janero DR. Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. Free Radic Biol Med. 1990;9(6):515-40. doi: 10.1016/0891-5849(90)90131-2. — View Citation
Kumar N, Singh AK. Trends of male factor infertility, an important cause of infertility: A review of literature. J Hum Reprod Sci. 2015 Oct-Dec;8(4):191-6. doi: 10.4103/0974-1208.170370. — View Citation
Mamin HJ, Kim M, Sherwood MH, Rettner CT, Ohno K, Awschalom DD, Rugar D. Nanoscale nuclear magnetic resonance with a nitrogen-vacancy spin sensor. Science. 2013 Feb 1;339(6119):557-60. doi: 10.1126/science.1231540. — View Citation
Thoma ME, McLain AC, Louis JF, King RB, Trumble AC, Sundaram R, Buck Louis GM. Prevalence of infertility in the United States as estimated by the current duration approach and a traditional constructed approach. Fertil Steril. 2013 Apr;99(5):1324-1331.e1. doi: 10.1016/j.fertnstert.2012.11.037. Epub 2013 Jan 3. — View Citation
Tomaiuolo R, Veneruso I, Cariati F, D'Argenio V. Microbiota and Human Reproduction: The Case of Female Infertility. High Throughput. 2020 May 3;9(2):12. doi: 10.3390/ht9020012. — View Citation
Weng SL, Chiu CM, Lin FM, Huang WC, Liang C, Yang T, Yang TL, Liu CY, Wu WY, Chang YA, Chang TH, Huang HD. Bacterial communities in semen from men of infertile couples: metagenomic sequencing reveals relationships of seminal microbiota to semen quality. PLoS One. 2014 Oct 23;9(10):e110152. doi: 10.1371/journal.pone.0110152. eCollection 2014. — View Citation
* Note: There are 14 references in all — Click here to view all references
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Free radical concentration in seminal plasma | Free radical concentration (in mola) in seminal plasma from males of couples visiting the Center of Reproductive Medicine (CRM) of the University Medical Center Groningen (UMCG) is measured using Diamond magnetometry. | Within 4 hours after production of semen at baseline | |
Primary | Determination of seminal microbiome species and their abundance in seminal plasma | The different species and their relative and absolute abundance in seminal microbiota is determined in seminal plasma using qPCR and 16S rRNA sequencing methods (%). | Baseline | |
Primary | Free radical concentration in serum using Diamond magnetometry | Free radical concentration (in mola) in blood serum from males of couples visiting the Center of Reproductive Medicine (CRM) of the University Medical Center Groningen (UMCG) is measured using Diamond magnetometry. | Within 2 hours of withdrawal at baseline | |
Primary | Free thiol levels in serum using the Ellman technique | Free thiol levels in blood serum (in umol/L) from males of couples visiting the Center of Reproductive Medicine (CRM) of the University Medical Center Groningen (UMCG) is measured using the Ellman technique. | Baseline | |
Primary | Malondialdehyde levels in serum using the TBARS assay | Malondialdehyde levels blood serum (in uM) from males of couples visiting the Center of Reproductive Medicine (CRM) of the University Medical Center Groningen (UMCG) is measured using the TBARS assay. | Baseline | |
Secondary | Relation between concentration of free radicals in semen and the microbiota species composition in seminal plasma | To relate the concentration of free radical in seminal plasma measured in uM with Diamond magnetometry, with the incidence of microbiota (e.g. which species and their abundance) in seminal plasma measured with qPCR and 16S rRNA sequencing methods, to detect a role of microbiota in the concentration of free radicals. Statistical analysis established using SPSS (IBM Corp, Armonk, NY USA). | Through study completion, an average of 1 year | |
Secondary | Relation between free radical concentration in seminal plasma and free radical concentration in blood serum. | To relate the concentration of free radicals in seminal plasma measured with Diamond magnetometry with the concentration of free radical in blood serum measured with Diamond magnetometry (uM), to compare systemic and local oxidative stress. Statistical analysis established using SPSS (IBM Corp, Armonk, NY USA). | Through study completion, an average of 1 year | |
Secondary | Relation between free radical concentration in seminal plasma and free thiol levels in blood serum. | To relate the concentration of free radicals in seminal plasma measured with Diamond magnetometry with the concentration of free thiols in blood serum (uM) measured with the Ellman technique (1959), to compare systemic and local oxidative stress. Statistical analysis established using SPSS (IBM Corp, Armonk, NY USA). | Through study completion, an average of 1 year | |
Secondary | Relation between free radical concentration in seminal plasma and concentration of Malondialdehyde in blood serum. | To relate the concentration of free radicals in seminal plasma measured with Diamond magnetometry with the concentration of Malondialdehyde (uM) using the thiobarbituric acid reactive substance assay (TBARS; Janero 1990), to compare systemic and local oxidative stress. Statistical analysis established using SPSS (IBM Corp, Armonk, NY USA). | Through study completion, an average of 1 year | |
Secondary | Relation between primary objectives (1-5) and seminal volume measured according to the WHO guidelines. | To relate the primary objectives (outcome 1-5) to the standard semen analysis parameter volume (cc) analyzed according to the WHO guidelines. Statistical analysis established using SPSS (IBM Corp, Armonk, NY USA). | Through study completion, an average of 1 year | |
Secondary | Relation between primary objectives (1-5) and sperm concentration measured according to the WHO guidelines. | To relate the primary objectives (outcome 1-5) to the standard semen analysis parameter sperm concentration (10^6/mL) analyzed according to the WHO guidelines. Statistical analysis established using SPSS (IBM Corp, Armonk, NY USA). | Through study completion, an average of 1 year | |
Secondary | Relation between primary objectives (1-5) and semen motility measured according to the WHO guidelines. | To relate the primary objectives (outcome 1-5) to the standard semen analysis parameter sperm motility (%/total ejaculate) analyzed according to the WHO guidelines. Statistical analysis established using SPSS (IBM Corp, Armonk, NY USA). | Through study completion, an average of 1 year | |
Secondary | Relation between primary objectives (outcome 1-5) and lifestyle factor: smoking, collected via routinely conducted hospital questionnaires. | To relate the primary objectives (outcome 1-5) to the smoking habit (measured in number of cigarettes/day), to detect a role for lifestyle in male infertility. Smoking habit will be collected as part of the standard care of the couples seeking fertility treatment with a questionnaire. Statistical analysis established using SPSS (IBM Corp, Armonk, NY USA). | Through study completion, an average of 1 year | |
Secondary | Relation between primary objectives (outcome 1-5) and lifestyle factor: BMI, collected via routinely conducted hospital questionnaires. | To relate the primary objectives (outcome 1-5) to the lifestyle factor BMI (kg/m^2), to detect a role for lifestyle in male infertility. BMI will be collected as part of the standard care of the couples seeking fertility treatment with a questionnaire. Statistical analysis established using SPSS (IBM Corp, Armonk, NY USA). | Through study completion, an average of 1 year | |
Secondary | Relation between primary objectives (outcome 1-5) and lifestyle factor: alcohol use, collected via routinely conducted hospital questionnaires. | To relate the primary objectives (outcome 1-5) to the alcohol use (measured in units alcohol/week), to detect a role for lifestyle in male infertility. Alcohol use will be collected as part of the standard care of the couples seeking fertility treatment with a questionnaire. Statistical analysis established using SPSS (IBM Corp, Armonk, NY USA). | Through study completion, an average of 1 year | |
Secondary | Relation between primary objectives (outcome 1-5) and medication use collected via routinely conducted hospital questionnaires. | To relate the primary objectives (outcome 1-5) to medication use (measured in daily dose in mg, ml or units), to detect an influence of medication use in male infertility. Medication list will be collected as part of the standard care of the couples seeking fertility treatment with a questionnaire. Statistical analysis established using SPSS (IBM Corp, Armonk, NY USA). | Through study completion, an average of 1 year | |
Secondary | Relation between primary objectives (outcome 1-5) and lifestyle factor: recreative drug use, collected via routinely conducted hospital questionnaires. | To relate the primary objectives (outcome 1-5) to recreative drug use (measured in type and amount of drugs/week), to detect a role for lifestyle in male infertility. Drug usage will be collected as part of the standard care of the couples seeking fertility treatment with a questionnaire. Statistical analysis established using SPSS (IBM Corp, Armonk, NY USA). | Through study completion, an average of 1 year | |
Secondary | Relation between primary objectives (outcome 1-5) and comorbidities, collected via routinely conducted hospital questionnaires. | To relate the primary objectives (outcome 1-5) to the comorbidities, to detect an influence of comorbidities within male infertility. Comorbidities will be collected as part of the standard care of the couples seeking fertility treatment with a questionnaire (number of cigarettes/day, number of units of alcohol/week, type and amount of drugs use per week). Statistical analysis established using SPSS (IBM Corp, Armonk, NY USA). | Through study completion, an average of 1 year | |
Secondary | Relation between primary objectives (outcome 1-5) and food intake collected using the food frequency questionnaire developed by Wageningen University. | To relate the primary objectives (outcome 1-5) to food intake to detect a role for diet in male infertility. Food intake will be collected using a food frequency questionnaire (FFQ) of the University of Wageningen where previous month is used as reference point to measure the rate of specific food groups. Statistical analysis established using SPSS (IBM Corp, Armonk, NY USA). | Through study completion, an average of 1 year |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03607409 -
Role of Inhibin A as Biomarker for Ovarian Response for IVF Treatment
|
||
Recruiting |
NCT02312076 -
GnRHa for Luteal Phase Support in Long GnRHa Protocol Cycles
|
Phase 4 | |
Terminated |
NCT02161861 -
Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study
|
N/A | |
Completed |
NCT03287479 -
Comparison of a Semi-automated Closed Vitrification System (Gavi®) With a Manual Open Vitrification Sytem (Cryotop®)
|
N/A | |
Terminated |
NCT03522350 -
Randomized Trial Comparing EmbryoScope With EmbryoScope+.
|
N/A | |
Completed |
NCT04496284 -
Embryo Transfer Outcomes After Vitrification With Slush Nitrogen Compared to Liquid Nitrogen
|
N/A | |
Completed |
NCT03623659 -
pArtiaL zonA pelluciDa Removal by assisteD hatchINg of Blastocysts
|
N/A | |
Completed |
NCT03895099 -
New Ovarian Stimulation With Random Start, Use of Progestin Protocol for Oocyte Donors
|
Phase 3 | |
Active, not recruiting |
NCT04142112 -
Randomized, Standard-Controlled, Study to Evaluate the Ohana IVF Sperm Preparation Kit, SPeRtility IVF Next Generation
|
N/A | |
Completed |
NCT03152643 -
Cumulative Live Birth Rates After Cleavage-stage Versus Blastocyst-stage Embryo Transfer
|
N/A | |
Recruiting |
NCT03683771 -
Assessment of Endometrial Pattern and Sub-endometrial Vascularity in ICSI Outcome
|
||
Recruiting |
NCT03161119 -
Comparing Two Different Embryo Transfer Catheters
|
N/A | |
Completed |
NCT04108039 -
Micronized Progesterone vs Gonadotropin-releasing Hormone (GnRH) Antagonist in Freeze-all IVF Cycles.
|
N/A | |
Completed |
NCT03677492 -
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Cytochalasin D ( ICSI-CD)
|
N/A | |
Completed |
NCT03678610 -
Handling Medium for ICSI With Ionomycin and Latrunculin A
|
N/A | |
Completed |
NCT03678558 -
Oocyte Vitrification Aided With Cytochalasin B
|
N/A | |
Completed |
NCT03678584 -
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Chaetoglobosin A ( ICSI-CA)
|
N/A | |
Completed |
NCT03678597 -
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Latrunculin B ( ICSI-LB)
|
N/A | |
Completed |
NCT03678818 -
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Latrunculin A (ICSI-LA)
|
N/A | |
Completed |
NCT03678571 -
Oocyte Vitrification Aided With Latrunculin A
|
N/A |